Copyright
©The Author(s) 2015.
World J Gastrointest Pharmacol Ther. Nov 6, 2015; 6(4): 137-144
Published online Nov 6, 2015. doi: 10.4292/wjgpt.v6.i4.137
Published online Nov 6, 2015. doi: 10.4292/wjgpt.v6.i4.137
Figure 2 Algorithm for selection of mesalazine formulations.
Anti-TNF: Anti-tumour necrosis factor; AEs: Adverse events; MMX: Multi-matrix system; OD: Once daily; CRP: C-reactive protein.
- Citation: Ye B, van Langenberg DR. Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal? World J Gastrointest Pharmacol Ther 2015; 6(4): 137-144
- URL: https://www.wjgnet.com/2150-5349/full/v6/i4/137.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v6.i4.137